.While the biotech financial investment scene in Europe has decreased somewhat following a COVID-19 ...
.After increasing $213 million in 2023-- among the year's largest exclusive biotech shots-- Volume B...
.Welcome to recently's Chutes & Ladders, our summary of substantial leadership hirings, shootings...
.Venture capital backing into biopharma cheered $9.2 billion around 215 handle the 2nd fourth of thi...
.Bicara Therapies and Zenas Biopharma have delivered new catalyst to the IPO market with filings tha...
.Genentech will close its own cancer immunology analysis division, as well as unit mind and also ren...
.Kezar Life Sciences is falling its own unpromising period 1 strong growth medicine as the biotech g...
.In spite of izokibep keeping its newfound winning touch in the clinic, Acelyrin is no longer focusi...
.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medicine cand...
.Ovid Therapeutics currently showed last month that it was trimming back its own headcount as the fi...